| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A treatment refractory CD30-positive diffuse large B cell lymphoma in the ileal neobladder
|
Ota, Saeko
|
|
2016
|
96 |
4 |
p. 683-684
|
article
|
| 2 |
Blastic plasmacytoid dendritic cell neoplasm with transient response to pralatrexate
|
Arranto, Christian
|
|
2016
|
96 |
4 |
p. 681-682
|
article
|
| 3 |
Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients
|
Youssry, Ilham
|
|
2017
|
96 |
4 |
p. 597-603
|
article
|
| 4 |
Comprehensive assessment of peripheral blood TCRβ repertoire in infectious mononucleosis and chronic active EBV infection patients
|
Liu, Shenglin
|
|
2017
|
96 |
4 |
p. 665-680
|
article
|
| 5 |
Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy
|
Hiller, Jan K.
|
|
2017
|
96 |
4 |
p. 559-565
|
article
|
| 6 |
Haploidentical hematopoietic bone marrow transplantation followed by living kidney transplantation from the same donor in a sickle cell disease patient with end-stage renal failure
|
Knüppel, Eva
|
|
2017
|
96 |
4 |
p. 703-705
|
article
|
| 7 |
Histoplasma capsulatum in a peripheral blood smear in a non-HIV patient
|
Jha, Bhawna
|
|
2016
|
96 |
4 |
p. 709-710
|
article
|
| 8 |
Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion
|
Breccia, Massimo
|
|
2016
|
96 |
4 |
p. 549-558
|
article
|
| 9 |
Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial
|
Magnano, Laura
|
|
2017
|
96 |
4 |
p. 639-646
|
article
|
| 10 |
Low-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity
|
Chan, Thomas S. Y.
|
|
2017
|
96 |
4 |
p. 647-651
|
article
|
| 11 |
Managing patients with myelofibrosis and low platelet counts
|
Al-Ali, Haifa Kathrin
|
|
2016
|
96 |
4 |
p. 537-548
|
article
|
| 12 |
Meis1 is critical to the maintenance of human acute myeloid leukemia cells independent of MLL rearrangements
|
Liu, Jiangying
|
|
2017
|
96 |
4 |
p. 567-574
|
article
|
| 13 |
Nutritional risk in allogeneic stem cell transplantation: rationale for a tailored nutritional pathway
|
Aoyama, Takashi
|
|
2017
|
96 |
4 |
p. 617-625
|
article
|
| 14 |
Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection
|
Chen, Miao
|
|
|
96 |
4 |
p. 581-587
|
article
|
| 15 |
Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection
|
Chen, Miao
|
|
2017
|
96 |
4 |
p. 581-587
|
article
|
| 16 |
Primary myelofibrosis and its targeted therapy
|
Shantzer, Lindsey
|
|
2016
|
96 |
4 |
p. 531-535
|
article
|
| 17 |
Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma
|
Pugliese, Novella
|
|
2017
|
96 |
4 |
p. 627-637
|
article
|
| 18 |
Rare myopathy associated to MGUS, causing heart failure and responding to chemotherapy
|
Belhomme, Nicolas
|
|
2017
|
96 |
4 |
p. 695-696
|
article
|
| 19 |
Resistance to arsenic trioxide and retinoic acid therapy in acute promyelocytic leukemia
|
Zhang, Xueya
|
|
2017
|
96 |
4 |
p. 707-708
|
article
|
| 20 |
Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis
|
Cerchione, Claudio
|
|
2017
|
96 |
4 |
p. 697-699
|
article
|
| 21 |
Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience
|
Yoo, Shin Hye
|
|
2017
|
96 |
4 |
p. 605-615
|
article
|
| 22 |
Second line azacitidine for elderly or infirmed patients with acute myeloid leukemia (AML) not eligible for allogeneic hematopoietic cell transplantation—a retrospective national multicenter study
|
Ram, Ron
|
|
2017
|
96 |
4 |
p. 575-579
|
article
|
| 23 |
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab
|
Alashkar, Ferras
|
|
2017
|
96 |
4 |
p. 589-596
|
article
|
| 24 |
Severe hepatitis B virus reactivation related to ibrutinib monotherapy
|
Herishanu, Yair
|
|
2017
|
96 |
4 |
p. 689-690
|
article
|
| 25 |
Successful treatment of refractory Sezary syndrome by anti-PD-1 antibody (nivolumab)
|
Shen, Kaini
|
|
2017
|
96 |
4 |
p. 687-688
|
article
|
| 26 |
Successful treatment with apixaban of sinus venous thrombosis due to pegylated asparaginase in a young adult with T cell acute lymphoblastic leukemia: case report and review of management
|
Talamo, Laura
|
|
2017
|
96 |
4 |
p. 691-693
|
article
|
| 27 |
The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry
|
Beijers, Antoinetta J.M.
|
|
2017
|
96 |
4 |
p. 653-663
|
article
|
| 28 |
Transient hypophysitis in a patient treated by duvelisib for chronic lymphocytic leukemia
|
Orioli, Laura
|
|
2017
|
96 |
4 |
p. 685-686
|
article
|
| 29 |
Vaccination of allogeneic hematopoietic stem cell transplant recipients—what should be considered?
|
Hilgendorf, Inken
|
|
2017
|
96 |
4 |
p. 701-702
|
article
|
Journal description